BiVictriX Therapeutics PLC
LSE:BVX
Cash Flow Statement
Cash Flow Statement
BiVictriX Therapeutics PLC
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||
| Net Income |
(3)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
1
|
1
|
0
|
0
|
0
|
0
|
|
| Cash Taxes Paid |
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
|
| Change in Working Capital |
(0)
|
0
|
0
|
0
|
1
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(3)
-48%
|
(2)
+10%
|
(2)
+4%
|
(2)
+15%
|
(2)
-16%
|
|
| Investing Cash Flow | |||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-320%
|
(0)
-80%
|
(0)
+9%
|
0
N/A
|
0
+1 012%
|
|
| Financing Cash Flow | |||||||
| Net Issuance of Common Stock |
8
|
8
|
0
|
0
|
2
|
2
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Other |
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
7
N/A
|
7
+0%
|
0
N/A
|
0
N/A
|
2
N/A
|
2
-3%
|
|
| Change in Cash | |||||||
| Net Change in Cash |
5
N/A
|
4
-20%
|
(3)
N/A
|
(3)
+5%
|
(0)
+100%
|
(0)
-2 588%
|
|
| Free Cash Flow | |||||||
| Free Cash Flow |
(2)
N/A
|
(3)
-55%
|
(3)
+3%
|
(3)
+5%
|
(2)
+26%
|
(2)
-8%
|
|